NCT04826627

Brief Summary

In 2018, the main societies of anesthesia (European Society Anaesthesiology, European Society Pediatric Anesthesia, and Association des Anesthésistes Réanimateurs Pédiatriques d'Expression Française) changed the current recommendations for preoperative fasting time in children, reducing the time to last intake of clear liquids from two to one hour before anesthetic induction. Prolonged fasting may have a deleterious impact on blood glucose homeostasis. The consequences of intraoperative hypoglycemia in children can be serious in the short term, but also in the long term. The objective of multicenter prospective, observational cohort study is to investigate- in children younger than 24 months of age undergoing scheduled conventional inpatient surgery- a correlation between the duration of preoperative fasting, glycemic intraoperative homeostasis and the criteria of enhanced recovery after surgery, which are the hospital length of stay (main outcome), postoperative pain and postoperative nausea-vomiting (secondary outcomes). By identifying non-adherence to fasting rules as one of the causes of prolonged hospitalization, this study will highlight the need to develop effective strategies to promote adherence to fasting rules in pediatric surgery and minimize the potential deleterious impact on intraoperative glycemic control.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

July 15, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2023

Completed
Last Updated

February 13, 2023

Status Verified

May 1, 2022

Enrollment Period

1.7 years

First QC Date

March 31, 2021

Last Update Submit

February 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • length of stay in hospital

    length of stay in hospital after surgery

    1 week

Interventions

capillary glycemia

Eligibility Criteria

Age0 Months - 24 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

* All children less than 24 months of age * scheduled for conventional inpatient surgery will be included

You may qualify if:

  • All children less than 24 months of age
  • scheduled for conventional inpatient surgery will be included

You may not qualify if:

  • Children receiving intravenous fluids during the fasting period
  • children managed in ambulatory surgery
  • children with an ASA score strictly greater than 3
  • children managed in the emergency operating room
  • children with an acute metabolic disorder
  • an endocrine pathology or a pathology requiring the chronic use of drugs modifying glycemia (insulin, oral antidiabetics, glucagon, gabapentin, antidepressants and neuroleptics, conversion enzyme inhibitors (CEI)
  • beta blockers, statins, anti-transplant treatments, corticoids, antimalarial drugs, the following antibiotics fluoroquinolones, doxycycline, sulfamethoxazole, trimethoprim)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU Caen Normandie

Caen, 14000, France

RECRUITING

Hôpital Necker Enfants Malades

Paris, 75015, France

NOT YET RECRUITING

MeSH Terms

Conditions

Hypoglycemia

Interventions

Blood Glucose

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

GlucoseHexosesMonosaccharidesSugarsCarbohydrates

Central Study Contacts

Jean-Philippe Salaün, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2021

First Posted

April 1, 2021

Study Start

July 15, 2021

Primary Completion

April 14, 2023

Study Completion

April 15, 2023

Last Updated

February 13, 2023

Record last verified: 2022-05

Locations